MYND Life Sciences Inc. (CSE: MYND)

Canada flag Canada · Delayed Price · Currency is CAD
0.0350
0.00 (0.00%)
Sep 26, 2024, 4:00 PM EDT
-22.22%
Market Cap 1.67M
Revenue (ttm) 1.00
Net Income (ttm) -694.07K
Shares Out 47.82M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open 0.0350
Previous Close 0.0350
Day's Range 0.0350 - 0.0350
52-Week Range 0.0050 - 0.1000
Beta 0.40
Analysts n/a
Price Target n/a
Earnings Date Aug 29, 2024

About MYND Life Sciences

MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO John Campbell
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol MYND
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.